Fortress Biotech, Inc.
FBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429260
No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.
Other share classesFBIOP
Q1 2023 vs. Q4 2022
How the institutions holding Fortress Biotech, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 49 | 1 | 54 | +6 |
| Shares | 27.5M | 72.0K | 28.6M | +1.19M (+4.3%) |
| Value | $18.0M | $47.0K | $23.4M | +$5.46M (+30.4%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Fortress Biotech, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Shikiar Asset Management Inc | 1,169,000 | $959.0K | 0.34% |
| Two Sigma Securities, LLC | 36,189 | $29.7K | 0.00% |
| Arete Wealth Advisors, LLC | 52,547 | $24.0K | 0.00% |
| LPL Financial LLC | 20,000 | $16.4K | 0.00% |
| Virtu Financial LLC | 13,221 | $11.0K | 0.00% |
| Spotlight Asset Group, Inc. | 10,700 | $7.00K | 0.01% |
| Simplex Trading, LLC | 4,261 | $3.00K | 0.00% |
| Group One Trading, L.P. | 2,000 | $1.64K | 0.00% |
| Citadel Advisors LLC | 1,737 | $1.42K | 0.00% |
| West Financial Advisors, LLC | 1,000 | $820 | 0.00% |
| Oliver Lagore Vanvalin Investment Group | 400 | $328 | 0.00% |
Sold out (5)
Institutions that held Fortress Biotech, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Oasis Management Co Ltd. | 985,222 | $645.3K |
| Ergoteles LLC | 118,561 | $77.7K |
| Connor, Clark & Lunn Investment Management Ltd. | 64,492 | $42.2K |
| Sepio Capital, LP | 63,500 | $41.6K |
| Cetera Investment Advisers | 23,500 | $15.4K |
Not filed for Q1 2023 yet (1)
Institutions that held Fortress Biotech, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Telemetry Investments, L.L.C. | 72,000 | $47.0K |